ArticleFrontiers in neurology2026
Elevated C-reactive protein-to-albumin ratio is associated with early neurological deterioration in acute ischemic stroke: a retrospective cohort study.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early neurological deterioration (END) is a frequent complication of acute ischemic stroke (AIS) that contributes to poor clinical outcomes. The C-reactive protein-to-albumin ratio (CAR) reflects systemic inflammation relative to albumin levels and may be associated with END. We evaluated the association between log Methods: We retrospectively analyzed 1,766 patients with AIS admitted between September 2016 to September 2022. END was defined as an increase of ≥2 points in the NIHSS motor item or total score within 72 h of admission. Associations between log₂-CAR and END were assessed using a multivariable logistic regression analysis. Generalized additive and two-piecewise regression models were used as exploratory analyses to assess potential non-linearity. ROC curves were used to compare CAR with established biomarkers and the A2DS2 score. Conclusion: Higher CAR was independently associated with END in this cohort. CAR's strongest predictive advantage was observed when compared with the A2DS2 clinical score, whereas superiority over CRP alone was not demonstrated. The possible threshold at a raw CAR of approximately 0.020 is exploratory and requires independent validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.